Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

0.8020
+0.04475.90%
Post-market: 0.82000.0180+2.24%16:22 EDT
Volume:1.40M
Turnover:1.12M
Market Cap:64.24M
PE:2.12
High:0.8250
Open:0.7700
Low:0.7602
Close:0.7573
Loading ...
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2022

Major Issues Report

8-K - Current report
Apr 14, 2022

Major Issues Report

8-K - Current report
Mar 23, 2022

Major Issues Report

8-K - Current report
Mar 04, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2022

Major Issues Report

8-K - Current report
Feb 01, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Jan 03, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities